Breaking News Instant updates and real-time market news.

ALXN

Alexion

$123.50

3.18 (2.64%)

14:51
08/29/18
08/29
14:51
08/29/18
14:51

Alexion offices visited by Brazilian tax authorities, Bloomberg says

An Alexion spokesperson told Bloomberg that the company provided documents to Brazil's tax authorities, who visited the company's offices as part of an audit.

  • 12

    Sep

  • 18

    Feb

ALXN Alexion
$123.50

3.18 (2.64%)

08/07/18
STFL
08/07/18
DOWNGRADE
Target $130
STFL
Hold
Alexion downgraded to Hold from Buy at Stifel
Stifel transferred coverage of Alexion to analyst Paul Matteis, who set a Hold rating and $130 price target on the shares, down from the firm's prior Buy rating. He has difficulty envisioning significant upside to mid-to-long-term consensus expectations given his worries about the risks associated with an increasingly challenging European payor environment and the breadth of drug development ongoing in the complement space, Matteis tells investors.
07/26/18
PIPR
07/26/18
NO CHANGE
PIPR
Piper Jaffray would be buyers on Alexion weakness
Piper Jaffray analyst Christopher Raymond said in a research note that he believes the pressure in Alexion is "more macro-driven than company specific." He noted that with a solid Q2 beat and FY18 raise, along with continued pipeline progress and increased certainty with regard to the complement inhibition franchise's revenue tail, there is much to like with this name, and he would recommend buying the name on weakness. He kept an Overweight rating and $170 price target on Alexion shares.
07/26/18
EVER
07/26/18
NO CHANGE
Target $158
EVER
Outperform
Alexion price target raised to $158 from $150 at Evercore ISI
Evercore ISI analyst Josh Schimmer said Alexion is "consistently conservative" on guidance and he wouldn't be surprised to see the company raise its outlook again in Q3 as it did with its Q2 report. He also noted that company reported "slight" delays for 1210 and its Wilson's program. Following the report, he raised his price target on Alexion to $158 and reiterated his Outperform rating on the shares.
06/15/18
OPCO
06/15/18
NO CHANGE
OPCO
Outperform
Large-cap biotech fundamentals slowly improving, says Oppenheimer
Ahead of Q2 biotech earnings starting in mid-July, Oppenheimer analyst Hartaj Singh tells investors in a research note that large-cap fundamentals and sector sentiment are "slowly but surely" improving. Improving fundamentals indicate that large-cap biotech results could outperform in Q2, with Gilead (GILD), Alexion (ALXN) and Vertex (VRTX) leading the charge. Singh called out Vertex as "one of our favorite large-cap biotech names," and also says he believes the negative sentiment around Regeneron (REGN) "might be peaking." Singh, who has Outperform ratings on Alexion and Vertex and a Perform rating on Gilead and Regeneron, says he is "cautiously bullish" on the sector.

TODAY'S FREE FLY STORIES

CLAR

Clarus Corporation

$10.45

-0.3 (-2.79%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Clarus Corporation management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

AMSC

AMSC

$6.33

-0.265 (-4.02%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
AMSC management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

NNBR

NN, Inc.

$15.65

-0.05 (-0.32%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
NN, Inc. to host two day investor day »

Two day investor day to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 06

    Nov

LBTYA

Liberty Global

$28.37

-0.87 (-2.98%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Liberty Global management to meet with Wolfe Research »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

TRU

TransUnion

$73.68

-0.62 (-0.83%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
TransUnion management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 23

    Oct

TSLX

TPG Specialty Lending

$20.56

-0.15 (-0.72%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
TPG Specialty Lending management to meet with JMP Securities »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

THR

Thermon Group

$25.98

-0.14 (-0.54%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Thermon Group management to meet with William Blair »

Group luncheon with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

04:55
09/25/18
09/25
04:55
09/25/18
04:55
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

September Richmond Fed…

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
AdvaMed to hold a conference »

MedTech Conference will…

IMPV

Imperva

$46.70

1.05 (2.30%)

, FIVN

Five9

$43.51

0.3 (0.69%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Microsoft to hold a conferenc e »

Microsoft Ignite will be…

IMPV

Imperva

$46.70

1.05 (2.30%)

FIVN

Five9

$43.51

0.3 (0.69%)

CDAY

Ceridian

$42.29

0.225 (0.53%)

MSFT

Microsoft

$114.72

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 06

    Nov

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

TEN

Tenneco

$44.59

-0.9 (-1.98%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Tenneco management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 29

    Oct

SWCH

Switch

$10.85

-0.21 (-1.90%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Switch management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
UBS waste market/recycling analyst to hold an analyst/industry conference call »

Analyst Windham, along…

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Stephens real estate services analyst to hold group luncheon »

Real Estate Services…

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Stephens retail/broadlines analyst to hold a luncheon meeting »

Specialty Pharmaceuticals…

ARKAY

Arkema

$0.00

(0.00%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Arkema management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

COOL

PolarityTE

$0.00

(0.00%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
PolarityTE management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NVDA

Nvidia

$265.72

2.28 (0.87%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Nvidia management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 10

    Dec

COWN

Cowen Group

$16.00

0.1 (0.63%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Cowen Group management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Oct

WTW

Weight Watchers

$72.88

3.11 (4.46%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Weight Watchers management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

STRA

Strategic Education

$137.53

0.72 (0.53%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Strategic Education management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

SRNE

Sorrento Therapeutics

$4.23

-0.075 (-1.74%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Sorrento Therapeutics management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXAS

Exact Sciences

$78.75

2.44 (3.20%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Exact Sciences management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

KRYS

Krystal Biotech

$17.68

0.8 (4.74%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Krystal Biotech management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 03

    Oct

GMED

Globus Medical

$54.09

-0.04 (-0.07%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Globus Medical management to meet with Leerink »

Meeting to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 09

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.